Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...

The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.

Licensed scientific and clinical intelligence integrated into the 3RnD platform to support AI-Driven Discovery and ...

BioNTech will present significant clinical trial data at the prestigious ASCO Annual Meeting, highlighting the advancement of its diversified oncology portfolio. The preliminary results for BNT327 and ...

For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...

As Gianakakos, Chief Medical Officer Edelberg and the rest of the Kardigan team continue developing their pipeline through ...

This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...

Please provide your email address to receive an email when new articles are posted on . Use of decentralized elements in cancer clinical trials did not have long-term negative effects on data quality.

New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures The research assesses how protocol design ...

Veeva eSource is part of the Veeva SiteVault platform and requires SiteVault CTMS at the site to simplify and streamline the ...

Clinical trials are the gold standard for understanding whether medical treatments work. They form the basis of whether drugs are approved by the FDA, and they’re used to demonstrate a drug’s ...

Choosing the right EDC (electronic data capture) platform is critical for sponsors, CROs, and clinical operations teams ...